Therapeutic Advances in Neurological Disorders
Scope & Guideline
Advancing knowledge for a brighter neurological future.
Introduction
Aims and Scopes
- Neurological Disorders Research:
The journal emphasizes research related to a wide range of neurological disorders, including multiple sclerosis, Parkinson's disease, epilepsy, and neuromuscular disorders. It aims to provide insights into the pathophysiology, diagnosis, and treatment of these conditions. - Clinical Trials and Efficacy Studies:
A significant focus is on clinical trials evaluating the efficacy and safety of therapeutic interventions. The journal publishes systematic reviews and meta-analyses that synthesize evidence from clinical studies to guide treatment decisions. - Innovative Therapeutic Approaches:
The journal explores novel therapeutic strategies, including pharmacological treatments, immunotherapies, and emerging technologies such as gene therapy and neurostimulation techniques. - Multidisciplinary Collaboration:
There is a strong emphasis on collaboration among various specialties within neurology, combining insights from clinical practice, basic research, and patient-centered care to advance treatment paradigms. - Patient-Centric Research:
The journal prioritizes studies that consider patient perspectives, treatment adherence, and quality of life, reflecting a commitment to improving patient outcomes in neurological disorders.
Trending and Emerging
- Precision Medicine in Neurology:
An increasing number of studies focus on precision medicine approaches, tailoring treatments based on individual patient characteristics such as genetic profiles and biomarkers. This trend is indicative of a broader movement towards personalized healthcare. - Neuroinflammation and Immune Modulation:
Research on neuroinflammation and its role in various neurological disorders is gaining prominence, with a focus on immune modulation therapies. This reflects a growing understanding of the immune system's impact on neurological health. - Digital Health and Telemedicine:
The integration of digital health technologies and telemedicine in managing neurological disorders is trending, particularly following the COVID-19 pandemic. Studies exploring the effectiveness of remote monitoring and treatment are becoming more common. - Real-World Evidence and Patient Registries:
There is a significant increase in the use of real-world evidence and patient registries to inform treatment patterns and outcomes. This trend emphasizes the importance of understanding how therapies perform in everyday clinical settings. - Machine Learning and Artificial Intelligence:
The application of machine learning and AI in predicting outcomes and personalizing treatment plans for neurological disorders is emerging as a significant area of research, reflecting the intersection of technology and medicine.
Declining or Waning
- Traditional Pharmacotherapy:
There has been a noticeable decline in publications focusing solely on traditional pharmacotherapy for neurological disorders, possibly due to the increasing interest in novel therapies and personalized medicine. - Basic Science Studies:
Research articles centered exclusively on basic science without direct clinical implications have decreased, as the journal shifts toward more translational research that bridges laboratory findings with clinical applications. - Single-Center Studies:
The prevalence of single-center observational studies has waned, likely due to a preference for multi-center collaborations that enhance the generalizability of findings and provide a broader patient perspective. - Historical Perspectives:
There is less emphasis on historical reviews of treatments and practices in neurology, as the focus has moved towards current innovations and future directions in therapeutic approaches. - Focus on Rare Disorders:
The journal appears to have reduced its emphasis on rare neurological disorders, potentially due to the limited available research and funding compared to more prevalent conditions.
Similar Journals
Neurology-Neuroimmunology & Neuroinflammation
Connecting researchers and clinicians in neuroimmunology.Neurology-Neuroimmunology & Neuroinflammation, published by LIPPINCOTT WILLIAMS & WILKINS, stands at the forefront of research in the rapidly evolving fields of neurology and neuroimmunology. Since its inception in 2014, this prestigious journal has embraced an Open Access model, ensuring that groundbreaking findings are readily available to researchers, clinicians, and students worldwide. Covering a broad spectrum of topics related to neuroinflammation, the journal has gained a remarkable reputation, attaining a Q1 ranking in both Neurology and Neurology (clinical) as of 2023, and ranking #6 out of 192 in the neuroscience category on Scopus. The journal's commitment to high-quality research aims to facilitate the understanding of neurological disorders, promote innovative therapies, and inspire collaboration among professionals. Addressing critical issues at the intersection of neurology, immunology, and clinical practice, Neurology-Neuroimmunology & Neuroinflammation is an essential platform for the dissemination of knowledge and the advancement of this vital field.
Expert Review of Neurotherapeutics
Exploring New Horizons in NeurotherapyExpert Review of Neurotherapeutics is an esteemed journal published by Taylor & Francis Ltd, focusing on the rapidly evolving field of neurotherapeutics. With an ISSN of 1473-7175 and an E-ISSN of 1744-8360, this publication aims to bridge the gap between clinical and preclinical research, providing a platform for innovative therapeutic strategies in neurology and neuroscience. The journal boasts impressive impact factor rankings, categorized as Q2 in both clinical neurology and miscellaneous neuroscience, and Q1 in medical pharmacology for 2023. Its reputable placement in Scopus rankings, including Rank #82/400 in clinical neurology, underscores its significance within the medical research community. Spanning from 2001 to 2024, the journal publishes critical reviews and original research articles aimed at enhancing understanding and treatment in neurological disorders. Although it currently does not offer open access, articles published in the journal are crucial for researchers, healthcare professionals, and students seeking to stay at the forefront of advancements in neurotherapeutics. With its strong emphasis on rigorous peer-reviewed content, Expert Review of Neurotherapeutics continues to be a vital resource for those dedicated to improving patient outcomes in the realm of neurology.
Seminars in Pediatric Neurology
Advancing knowledge in pediatric neurology.Seminars in Pediatric Neurology, published by W B SAUNDERS CO-ELSEVIER INC, is a prestigious journal dedicated to the evolving field of pediatric neurological disorders. Since its inception in 1994, this peer-reviewed journal has provided critical insights and cutting-edge research to support healthcare professionals in enhancing the quality of care for children with neurological conditions. With an impressive 2023 impact factor and a Q2 ranking in both the clinical neurology and pediatrics categories, it stands as a vital resource, fostering the dissemination of knowledge among researchers and clinicians alike. Featuring articles that explore a range of topics from clinical trials to innovative treatment modalities, this journal empowers practitioners with the latest findings in pediatric neurology. While primarily subscription-based, it plays a key role in bridging the gap between academia and clinical practice, making it an indispensable tool for anyone involved in the care and treatment of pediatric neurological patients.
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
Navigating the Evolving Landscape of Mental HealthFORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE is a pivotal journal in the fields of neurology, psychiatry, and related medical disciplines, published by GEORG THIEME VERLAG KG in Germany. With a history dating back to 1955, this journal has evolved to address the dynamic nature of neurological and psychiatric research, offering valuable insights and advancements in the field. Despite holding a Q4 category status in various medical domains according to the 2023 quartiles, the journal continues to foster academic discussion and engagement among researchers and clinicians alike. It serves as a vital platform for disseminating knowledge through original research articles, reviews, and clinical studies, making it an essential resource for professionals and students aiming to stay abreast of the latest developments in mental health and neurological science. Although the journal currently does not offer open access options, its contribution to the academic community is significant, helping to illuminate the intricate relationships between neurological disorders and psychiatric conditions.
KLINISCHE NEUROPHYSIOLOGIE
Exploring the intersection of physiology and neurology.KLINISCHE NEUROPHYSIOLOGIE is a pivotal journal dedicated to advancing the field of clinical neurophysiology, published by GEORG THIEME VERLAG KG in Germany. With an ISSN of 1434-0275 and an E-ISSN of 1439-4081, this journal aims to disseminate high-quality research findings that enhance our understanding of neurological disorders and their physiological underpinnings. Although currently positioned in the fourth quartile in both Neurology (clinical) and Physiology (medical) categories, the journal offers a unique platform for novel insights and empirical studies, filling a crucial niche within the medical community. Researchers, healthcare professionals, and students can benefit from its Open Access option, which promotes wider accessibility and engagement with cutting-edge scientific discourse. As the journal converges through the years from 1998 to 2024, it remains committed to fostering scholarly collaboration and innovation in neurophysiological research, crucial for improving clinical outcomes.
Archives of Neuroscience
Advancing neuroscience through innovative research.Archives of Neuroscience is a multidisciplinary journal dedicated to advancing the field of neuroscience through the publication of original research articles, review papers, and case studies. Published by BRIEFLAND, this journal aims to bridge the gap between neuroscience research and clinical applications, fostering a deeper understanding of brain function, neurological disorders, and potential therapeutic approaches. With an ISSN of 2322-3944 and an E-ISSN of 2322-5769, Archives of Neuroscience serves as an essential platform for researchers, professionals, and students alike, encouraging open access to knowledge and insights that drive innovation in the field. Although coverage was discontinued in Scopus from 2016 to 2017, the journal continues to uphold rigorous standards of academic excellence, making it a valuable resource for the neuroscience community seeking to explore and disseminate new findings. The journal is committed to providing timely access to research tools and findings that are crucial for informed decision-making in both academic and clinical settings.
JOURNAL OF CHILD NEUROLOGY
Exploring New Horizons in Pediatric Brain HealthThe JOURNAL OF CHILD NEUROLOGY is a distinguished publication in the critical fields of neurology and pediatrics, published by SAGE PUBLICATIONS INC. With its ISSN 0883-0738 and E-ISSN 1708-8283, this journal has been a pivotal resource since its inception in 1986, serving the needs of researchers, clinicians, and students dedicated to advancing the understanding and treatment of neurological disorders in children. As evidenced by its impressive Q2 rankings in both Neurology (clinical) and Pediatrics, Perinatology, and Child Health, the journal has established a reputable position within the academic community, ranking in the 75th percentile for pediatrics and the 53rd percentile for clinical neurology. This periodical not only contributes to the body of knowledge in child neurology but also promotes interdisciplinary collaboration, engaging a global audience through innovative research articles and case studies. Although the journal is not open access, it remains committed to disseminating high-quality research aimed at improving pediatric health outcomes, making it an essential read for professionals and researchers dedicated to this crucial area of medicine.
Neurology International
Exploring the Frontiers of Neurological ScienceNeurology International is a prestigious open-access journal published by MDPI that has been making significant contributions to the field of neurology since its establishment in 2009. With its ISSN 2035-8377, this journal is committed to disseminating high-quality, peer-reviewed research that addresses a wide range of clinical topics in neurology. Operating out of Basel, Switzerland, the journal holds a respectable Q2 ranking in the clinical neurology category as of 2023, indicating its influence and dedication to advancing scientific knowledge. Researchers and practitioners alike will find value in its comprehensive articles, which are readily accessible to a global audience, facilitating the sharing of innovative findings and clinical practices. As it converges towards 2024, Neurology International continues to provide a vital platform for scholarly discourse, aiming to improve patient outcomes and enhance our understanding of neurological disorders.
RESTORATIVE NEUROLOGY AND NEUROSCIENCE
Advancing Neural Restoration: Pioneering Research in Neurology and NeuroscienceRESTORATIVE NEUROLOGY AND NEUROSCIENCE, published by IOS PRESS, is a premier journal dedicated to advancing the fields of neurology and neuroscience. Since its inception in 1989, this journal has played a crucial role in disseminating cutting-edge research findings and innovative therapeutic approaches that aim to restore neurological function and improve patient outcomes. With a focus on developmental neuroscience and clinical neurology, the journal holds a 2023 Scopus ranking of #129 out of 400 in clinical neurology, and #15 out of 37 in developmental neuroscience, reflecting its significant influence in these domains. Although it operates on a non-open access model, RESTORATIVE NEUROLOGY AND NEUROSCIENCE offers valuable insights for researchers, healthcare professionals, and students seeking to deepen their understanding of neural restoration mechanisms and therapeutic strategies. Located in Amsterdam, Netherlands, the journal continues to foster scholarly dialogue and innovation, contributing to the global advancement of neuroscience and neurology.
Progress in Neurology and Psychiatry
Bridging research and practice for better mental health outcomes.Progress in Neurology and Psychiatry is a pivotal journal published by John Wiley & Sons Ltd, dedicated to advancing the fields of neurology and psychiatry. With a robust history dating back to its establishment, this esteemed journal holds a consistent Q3 ranking in 2023 across several categories including Neurology, Clinical Neurology, Psychiatry, and Mental Health, signifying its significant contribution to the scientific community. This journal serves as a vital source of knowledge and insight, publishing original research, reviews, and case studies that explore the intricacies of neurological and psychiatric disorders. Although it does not offer open access, the journal remains accessible to a wide audience through institutional subscriptions. By fostering a platform for scholarly discourse, Progress in Neurology and Psychiatry aims to bridge the gap between research and practice, ultimately enhancing the quality of care for individuals with neurological and psychiatric conditions. Researchers, clinicians, and students are encouraged to engage with the journal's comprehensive content to stay informed of the latest developments and emerging trends in these critical fields of medicine.